Drugmaker Sinergium Biotech, based in Argentina, will lead a project to accelerate the development of a human vaccine against the H5N1 avian flu virus, said the World Health Organization and the Medicines Patent Pool on Monday. The project is aimed at pharmaceutical companies in low- and middle-income nations and intended to bolster pandemic preparedness worldwide.… » Read More
The Ag Insider content is only available to members.